Yanxia Huang

Dr. Yanxia Huang

Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in Journal of International Medical Research
Verified
Journal Article
Open access
PDF file
YHYanxia Huang
Yanxia Huang
RZRenjing Zhang
Renjing Zhang
MMMei Meng
Mei Meng
DCDechang Chen
Dechang Chen
YDYunxin Deng
Yunxin Deng
Diquat is a widely used herbicide that is substituted for paraquat. With paraquat off the market, cases of diquat poisoning have been gradually increasing. The kidney is the most frequently impaired organ in diquat poisoning. Few cases of multiple organ failure caused by diquat have been reported. We herein describe a 30-year-old man who orally ingested about 160 mL of enriched diquat. Despite aggressive treatment, the patient’s condition progressed to multiple organ failure and death. The pulmonary lesions in this patient were different from those previously reported. This patient did not die of renal failure but of severe respiratory failure. He exhibited three different stages of pulmonary disease. The lung lesions in this case were unique. We hope that doctors will pay more attention to the lung lesions in patients with diquat poisoning in future and find new treatment methods to save the lives of such patients.

21 April 2022 in Food Chemistry
Verified
Journal Article
Closed access
YHYanxia Huang
Yanxia Huang
XBXianyang Bao
Xianyang Bao
PLPan Li
Pan Li
LZLei Zhan
Lei Zhan
HWHai Wu
Hai Wu
PCPei Chen
Pei Chen

8 June 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
YHYanxia Huang
Yanxia Huang
YDYunxin Deng
Yunxin Deng
RZRenjing Zhang
Renjing Zhang
MMMei Meng
Mei Meng
DCdechang chen
dechang chen
Background: Studies have shown that dexmedetomidine improves neurological function. Whether dexmedetomidine reduces mortality or improves quantitative electroencephalography (qEEG) among patients post-craniotomy remains unclear. Methods: This single-center randomized study was conducted prospectively from 1 January 2019 to 31 December 2020. Patients who were transferred to the ICU after craniotomy within 24 h were included. The analgesic was titrated to a Critical care Pain Observation Tool (CPOT) score ≤2, and the sedative was titrated to a Richmond Agitation–Sedation Scale (RASS) score ≤−3 for at least 24 h. The qEEG signals were collected by four electrodes (F3, T3, F4, and T4 according to the international 10/20 EEG electrode practice). The primary outcome was 28-day mortality and qEEG results on day 1 and day 3 after sedation. Results: One hundred and fifty-one patients were enrolled in this study, of whom 77 were in the dexmedetomidine group and 74 in the midazolam group. No significant difference was found between the two groups in mortality at 28 days (14.3% vs. 24.3%; p = 0.117) as well as in the theta/beta ratio (TBR), the delta/alpha ratio (DAR), and the (delta + theta)/(alpha + beta) ratio (DTABR) between the two groups on day 1 or day 3. However, both the TBR and the DTABR were significantly increased in the dexmedetomidine group. The DTABR in the midazolam group was significantly increased. The DAR was significantly increased on the right side in the dexmedetomidine group (20.4 (11.6–43.3) vs. 35.1 (16.7–65.0), p = 0.006) as well as on both sides in the midazolam group (Left: 19.5 (10.1–35.8) vs. 37.3 (19.3–75.7), p = 0.006; Right: 18.9 (10.1–52.3) vs. 39.8 (17.5–99.9), p = 0.002). Conclusion: Compared with midazolam, dexmedetomidine did not lead to a lower 28-day mortality or better qEEG results in brain injury patients after a craniotomy.


31 August 2025 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
YLYuxiang Li
Yuxiang Li
XWXia Wang
Xia Wang
LZLidi Zhang
Lidi Zhang
YHYanxia Huang
Yanxia Huang
YLYong’aN Liu
Yong’aN Liu
Background: Pneumonia with an empyema caused by anaerobic bacteria is rare but can be life-threatening, especially in immunocompromised patients. Case presentation: A 67-year-old man with diabetes and hypertension who presented with pneumonia and pleural effusion and was unresponsive to initial broad-spectrum antibiotics is presented. Next-generation sequencing identified Parvimonas micra and other pathogens. Therefore, targeted therapy with levornidazole was initiated. The patient's condition improved significantly after this treatment. Conclusions: This case highlights the importance of considering anaerobic bacteria in immunocompromised patients and the utility of next-generation sequencing in identifying atypical pathogens.